Use of Antibiotic Carrier in Acute Periprosthetic Infections (APPI) of Total Knee Replacements



Status:Completed
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:2/7/2015
Start Date:April 2014
End Date:December 2015
Contact:Michael P Muldoon, MD
Email:mpmuldoon@cox.net
Phone:858-278-8300

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Use of Antibiotic Contained Calcium Sulfate Carrier in Acute Periprosthetic Infections(APPI) of Total Knee Replacements

The purpose of the study is to gather information on the use of Stimulan, the surgery, and
anitbiotics to whetether the APPI has decreased or shown improvement when compared to study
participants who did not receive Stimulan during their revision total knee replacement
surgery.


Inclusion Criteria:

- APPI within 28 days of primary TKR

- Acute hematogenous infection within 4 weeks of symptoms

Exclusion Criteria:

- Exposed prosthesis

- Infection occuring in revised joints

- Poly articular infections

- have allergies to tobramycin or Vancomycin

- previous chronic infections in or around any ipsilateral extremity trauma or implants
We found this trial at
1
site
Southwest Orthopedic Group, LLP
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials